Title: Advancement Treatment for Neonatal Development

Abstract:

Advancement Treatment for Neonatal Development

There are various risk factors to neonatal development during neonatal period at the first four weeks of a child’s life. Neonatal development in this period, it presents critical in brain-nerve system maturation, cardiovascular and pulmonary development, this time for a child face to risks at developing of different diseases:

1. Fetal Diseases, as Fetal Nutrition Disorders or Fetal Oxygen Distress;
2. Hereditary Diseases, as Kartagener Syndrome or Cystic Fibrosis;
3. Congenital Abnormal Diseases, as Digestive System Abnormalities or Cardiovascular Abnormalities;
4. Newborn Diseases, as, Persistent Fetal Circulation Syndrome, Neonatal Respiratory Distress Syndrome. And Immunology Immaturity

Neonatal development has studied, and genetic reasons are in basic role to develop diseases of Hereditary Diseases and Congenital Defect or Newborn Diseases. Environmental risk factors are also observed to neonatal development, the risks to neonatal are either from maternal or from the child self by mediated with the factors of infection, nutrition or function immaturity.

The advance treatment in neonatal is applied in life support treatment with oxygen supply, monitor observation and warm keeping assistant machine; pharmacology therapy, surfactant replacement or nitric oxide inhalation therapy and ECMO in pulmonary cardiological support therapy to clinical abnormal presentation. Medical Collaboration has role in critical care for neonatal diseases, there have Neonatal Intensive Care Unit, ambulance transfer and basic research based on national trust groups.

Biography:

Dr. Yan Wang is a doctor and scientist in Medicine Science, she has Medicine Bachelor degree(M.D) in General Medicine and Pediatrics in 1990, and she also has the Doctoral Philosophy Degree(Ph.D) in Emergency and Pulmonary Medicine in 1998 from the Fudan University Medical School in China. She has worked in postdoctoral Scholar and investigator role in the United States of America since 2000 at the University of Miami Medicine School, Jefferson Healthy System Albert Einstein Medical Center and University of Pennsylvania Medicine School. She has critical working experience at the Imperial College in London in 2014. Currently she is attending doctor, professor, author, leader and committee member at hospitals, universities, organizations and Journal Presses with appointed positions.

She has published first-authored articles on peer-reviewed journals and conference abstracts about 100 products, She has written medical books over 10 books in English versions published in the United States or the United Kingdom. Her publications reflect her contribution at Science, Medicine and special Pediatrics. As well, she has working experience at speeches, teaching-courses, textbook and news release during the past more than 25 years longer.

Currently she is in charge of ongoing scholarly project as writing medical books and being organization committee; as she is in endeavor of awarded or honored in science achievement and spiritual life, it has included in my article and theory.